🔎 Trials Near Me

Home › Ovarian Cancer › Florida › Tampa

Ovarian Cancer clinical trials in Tampa, FL

21 studies for Ovarian Cancer are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of AVZO-021 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • Avenzo Therapeutics Recruiting Site, Tampa
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

RecruitingObservational study
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RecruitingPhase 3
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

RecruitingPhase 1
  • Moffitt, Tampa
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • Moffitt Cancer Center and Research Institute, Tampa
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT05316129

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07487168

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

RecruitingPhase 2
  • Tampa General Hospital Cancer Institute, Tampa
Ages 18 and older · Women · Updated Sep 14, 2026 · NCT06787612

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 15 and older · All sexes · Updated Aug 25, 2026 · NCT06276491

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Ages 35 to 50 · Women · Updated Aug 7, 2026 · NCT04251052

Clinical Pre-screening Protocol for Ovarian Cancer

RecruitingObservational study
  • Moffitt Cancer Center, Tampa
Ages 18 and older · Women · Updated Jul 30, 2026 · NCT03877796

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecruitingPhase 1/2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT05568680

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

RecruitingPhase 1/2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

RecruitingPhase 1
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT04890613

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Tampa
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • Exelixis Clinical Site #16, Tampa
Ages 18 and older · All sexes · Updated Sep 5, 2025 · NCT05932862

About Ovarian Cancer

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

More about Ovarian Cancer on MedlinePlus

Ovarian Cancer trials in other cities

Other studies in Tampa

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.